Introduction
============

ZFP57 is a Kruppel-associated box (KRAB) containing zinc-finger protein, preferentially expressed early in development.^[@bib1]^ ZFP57 has been shown in the mouse to act as a transcriptional regulator and is important in maintenance of imprinting,^[@bib2],\ [@bib3]^ regulating chromatin modifications and DNA methylation at murine imprinted loci in ES cells with the co-factor KRAB-associated protein 1 (KAP1/TRIM28).^[@bib4]^ *ZFP57* loss-of-function mutations are known to cause a hypomethylation disorder presenting as transient neonatal diabetes (TND) associated with a unique epigenetic profile at the TND differentially methylated region and other imprinted loci such as *GRB10* and *PEG3*,^[@bib5]^ but the biology of ZFP57 in humans is not well characterized. Recently we showed that the expression of *ZFP57* was dependent on underlying genetic variation.^[@bib6]^ Given the location of *ZFP57* in the MHC class I region, we sought to resolve the association and investigate the relationship with disease.

Materials and methods
=====================

Volunteer recruitment, cell purification, cell culture, RACE, genotyping, imputation, eQTL mapping and relationship with reported GWAS were performed as detailed in [Supplementary Information](#sup1){ref-type="supplementary-material"}.

Results
=======

We aimed to define the genetic modulators of *ZFP57* transcription by expression quantitative trait (eQTL) mapping. Alternatively spliced isoforms are well characterized for murine *Zfp57*^[@bib1]^ and a number of isoforms are annotated in humans ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). In order to take account of this when quantifying *ZFP57* expression, we first characterized transcription in lymphoblastoid cell lines (LCLs) and peripheral blood mononuclear cells (PBMCs) from volunteers identified as expressing *ZFP57*. Rapid amplification of cDNA ends (RACE) using 3′ and 5′ adapted cDNA from the COX LCL, known to be a high expresser of *ZFP57*,^[@bib6]^ and PCR with exon spanning primers revealed a previously unrecognized isoform, in which exon 2 is skipped and predicted to have a significantly truncated KRAB domain ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Quantification of *ZFP57* using isoform-specific primers or primers spanning exons 3/4 to capture both isoforms revealed low but detectable expression in PBMCs, ES cells and several adult tissues, notably the thymus and kidney ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}). Relative abundance of the different isoforms remained consistent between different tissues and across individuals ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}).

We proceeded to eQTL mapping in a cohort of 288 healthy volunteers^[@bib7]^ using primers spanning exons 3/4 to quantify transcript abundance in PBMCs. Following processing and quality control filtering, we analysed 651 210 SNP markers for 283 individuals. This revealed a major eQTL for *ZFP57* with the most significant associated SNP rs375984 (*P* = 9.3 × 10^−50^) in the second intron of *ZFP57* ([Figure 1a and b](#fig1){ref-type="fig"}). Analysis of purified monocytes from the same volunteers confirmed a strong eQTL, the most significant association was to rs375984 (*P*=3.2 × 10^−11^; [Supplementary Figure S2](#sup1){ref-type="supplementary-material"}). To further resolve this, we imputed 19 129 additional SNPs within 250 kb, which revealed three more strongly associated variants in the first intron of *ZFP57* in perfect LD (rs416568, rs365052 and rs2747431, *P*=4.6 × 10^−52^; [Figure 1c and d](#fig1){ref-type="fig"}). We determined the functional genomic landscape for these eSNPs using data from the ENCODE project.^[@bib8]^ Analysis of DNase-seq and ChIP-seq data sets resolved rs365052 is a candidate regulatory variant located in a DNase I hypersensitive site with evidence of CTCF binding ([Figure 1d](#fig1){ref-type="fig"}).

Analysis of the eQTL by HLA type showed association with HLA-A\*01 and \*23, but was not more informative than SNP markers ([Figure 2](#fig2){ref-type="fig"}). For the two most common ancestral haplotypes among Europeans, we found that volunteers with a copy of HLA-A1-B8-DR3 (*n*=19) had higher expression of *ZFP57* compared to HLA-A3-B7-DR15 (*n*=12; Mann--Whitney, *P*\<0.0001).

We investigated whether the genetic variants identified here as associated with *ZFP57* expression may be significant in common disease given the many disease associations reported involving the MHC class I region. We interrogated GWAS data sets and found intersection of *ZFP57* eSNPs variants with reported disease associations involving malignancy, HIV/AIDS and autoimmunity ([Table 1](#tbl1){ref-type="table"}). These included nasopharyngeal carcinoma and prostate cancer, the latter involving disease risk based on gene--gene interaction with the tumour suppressor gene *NKX3-1*. Associations were also noted involving HIV-1 viral set point and disease progression to AIDS.

Discussion
==========

We found that a significant minority of people show low-level transcription of *ZFP57* in adult cells and tissues, where it may modulate epigenetic processes, and that this is dependent on a strong local eQTL for *ZFP57*. Further work is required to resolve the functional basis for this, but a potential mechanism involves modulation of a novel regulatory element involving CTCF binding in the first intron of *ZFP57*. Our data also highlighted a potential role for *ZFP57* eSNPs in traits including cancer and HIV/AIDS. KRAB-ZNF genes play a role in epigenetic processes critical to cancer, including silencing of tumour suppressor genes, while the co-factor KAP1 is involved in oncogenesis.^[@bib9]^ DNA methylation is involved in establishing latency by retroviruses with hypermethylation of the viral 5\' long terminal repeat characteristic of HIV-1 aviraemic patients.^[@bib10]^ To date in humans, ZFP57 has only been associated with maintenance and not establishment of DNA methylation,^[@bib5]^ though a role in *de novo* methylation has been reported in mice.^[@bib2]^ The identification of a novel shorter isoform of ZFP57 may be functionally significant given the resulting severely truncated KRAB domain, which is likely to limit interaction with KAP1.

Complex LD structure in the MHC together with differences in SNP coverage between genotyping platforms necessitates further work to establish whether the most significant *ZFP57* eSNPs are also most informative for disease association and to explore the biological significance and relative importance of this observation in the context of extensive haplotype-specific expression in the MHC for other genes^[@bib6]^ with multiple *cis*- and *trans*-eQTL identified for this genomic region.^[@bib7]^

We have presented evidence that *ZFP57* is expressed more widely than previously appreciated, notably beyond development, and that this is dependent on underlying genetic variation. Further work is needed to investigate the role of ZFP57 in epigenetic regulation, notably in terms of cancer and HIV infection where expression associated SNPs may play a role and epigenetic mechanisms are known to be important.
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![Genetic modulators of *ZFP57* expression. (**a**) Manhattan plot showing strength of association plotted as --log10(P) values by chromosome for *ZFP57* expression. (**b**) Scatter/box and whiskers plot of *ZFP57* expression by rs375984 allele demonstrating significant differences between the different genotype groups (*P*\<0.0001, Kruskal--Wallis test). (**c**) Local association and recombination plot. Single marker allelic association results for a 215 kb region spanning *ZFP57* plotted as --log10(P) values (left y-axis) by genomic coordinate (x-axis). With reference to rs2747431 (which is in complete LD with rs416568 and rs365052), typed SNPs are shown in red (*r*^2^\>0.8), orange (0.5--0.8), yellow (0.2--0.5) and white (\<0.2). Imputed SNPs are shown in grey. Recombination rate is also plotted (right y-axis). (**d**) Functional genomic landscape for *ZFP57* (chr6:29640242-29650866) providing context for observed eSNPs, including rs375984, rs416568, rs365052 and rs2747431. Data are shown from the ENCODE project, accessed through the UCSC Genome Browser (<http://genome.ucsc.edu/>), resolving a DNase I hypersensitive site and evidence of CTCF binding in the region of rs365052 based on profiling of ES cells, LCLs (GM12878, GM12891) and CD20+ B cells. Linkage disequilibrium plot for the locus based on *r*^2^ is shown below including 115 SNPs (1000 Genomes CEU phase 1).](ejhg2013244f1){#fig1}

![Association between *ZFP57* expression, eSNPs and classical HLA types. *HLA-A*, *HLA-B*, *HLA-C*, *HLA-DRB*, *HLA-DQA* and *HLA-DQB* shown at two-digit resolution with *ZFP57* expression in PBMCs quantified by qPCR. Expression values are plotted for each individual corresponding to each HLA allele and coloured based on rs2747431 genotype (individuals with CC genotype at rs2747431 shown in red, CT in green and TT in blue). Two *ZFP57* expression values are plotted for each individual corresponding to each allele. There was evidence of association for HLA-A\*01 and HLA-A\*23 alleles (*P*\<0.0001 when analysed using a Mann--Whitney test).](ejhg2013244f2){#fig2}

###### Diseases and traits from the Catalogue of Published Genome-Wide Association Studies ([www.genome.gov/gwastudies](http://www.genome.gov/gwastudies), Accessed May 2012) in which reported GWAS SNPs are also eSNPs for *ZFP57* expression

  *Disease/trait*                                        *PUBMED ID*   *First author*      *SNP*     *GWAS P-value*   *eQTL P-value*  *r*^*2*^ *with peak eSNP*
  ------------------------------------------------------ ------------- ---------------- ----------- ---------------- ---------------- ---------------------------
  *Cancer*                                                                                                                            
   Nasopharyngeal carcinoma                              19664746      Tse KP            rs3129055   7.4 × 10^−11^    5.4 × 10^−39^   0.61
   Nasopharyngeal carcinoma                              20512145      Bei JX            rs2860580   4.9 × 10^−67^    7.0 × 10^−07^   0.22
   Prostate cancer (gene × 10 gene interaction)          22219177      Tao S             rs2523395   1.5 × 10^−06^    1.3 × 10^−13^   0.35
                                                                                                                                       
  *Autoimmune disease*                                                                                                                
   Graves\' disease                                      21900946      Nakabayashi K     rs3893464   1.9 × 10^−20^    1.1 × 10^−18^   0.47
   Multiple sclerosis                                    19525953      De Jager PL       rs2523393   1.0 × 10^−17^    1.3 × 10^−13^   0.35
                                                                                                                                       
  *HIV/AIDS*                                                                                                                          
   AIDS progression                                      19115949      Limou S            rs8321     4.7 × 10^−07^    5.5 × 10^−14^   0.30
   HIV-1 control                                         20041166      Fellay J          rs259919    3.0 × 10^−07^    9.8 × 10^−14^   0.22
                                                                                                                                       
  *Other*                                                                                                                             
   Drug-induced liver injury (amoxicillin-clavulanate)   21570397      Lucena MI         rs2523822   1.8 × 10^−10^    4.6 × 10^−07^   0.21
   IgE levels                                            22075330      Granada M         rs2571391   1.2 × 10^−15^    1.8 × 10^−06^   0.23

*r*^2^ between these SNPs and the peak ZFP57 eQTL, tagged by rs2747431, is shown.
